#USA #Austin #Texas Cardiac #Arrhythmia Institute #Heart Rhythm

Texas Cardiac Arrhythmia Institute's International Symposium on Heart Rhythm Disorders

In late May 2026, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center proudly held the eighth international symposium dedicated to complex heart rhythm disorders. This year, the event attracted a remarkable turnout of 1,600 medical experts from around the globe, including participants from countries like Belgium, Brazil, Canada, Colombia, and Italy, with 200 attendees joining in person.

The symposium, known as EP Live 2026, was a gathering of physicians, advanced practice nurses, and other healthcare professionals who focus on diagnosing and treating complex arrhythmias, which are irregular heart rhythms that can lead to serious complications. The educational program featured live broadcasts of innovative heart procedures complemented by commentary from leading experts, directly from the state-of-the-art Electrophysiology Center at St. David's Medical Center.

Dr. Andrea Natale, the executive medical director of TCAI and a leading cardiac electrophysiologist, expressed that the increased participation at EP Live 2026 highlights a growing demand for practical education based on real clinical cases and collaboration amongst specialists. He stated, “Sharing knowledge, innovation, and experiences in such a forum can accelerate the advancement of cardiac care and improve treatment outcomes for millions suffering from rhythm disorders.”

One of the most notable presentations involved a pioneering approach that combined two treatment methods—atrial fibrillation ablation and left atrial appendage closure—into a single procedure for patients with atrial fibrillation who are at increased risk of stroke. This innovative solution not only reduces the need for multiple interventions but also minimizes potential complications associated with separate procedures.

Additionally, live presentations also showcased the latest advancements in pulse field ablation, which is an energy-independent method utilizing short, high-charge electrical impulses to target and eliminate cells in the heart tissue responsible for arrhythmias, effectively without the risks associated with temperature-based energy methods.

The EP Live program included four sessions featuring live procedural broadcasts and previously recorded clinical case studies from TCAI and leading institutions worldwide, such as the International Center for Arrhythmias in Colombia, Centro Cardiologico Monzino in Italy, and renowned hospitals like Cleveland Clinic, Houston Methodist, and Massachusetts General in the US.

Attending physicians had the opportunity to earn a maximum of 14.5 AMA PRA Category 1 Credits™ awarded by the American Medical Association (AMA). The success of this symposium not only serves to advance knowledge among medical professionals in the field but also represents a crucial step toward improving cardiac care globally.

For further information, visit EP-Live.com or contact Matt Grillie via email at [email protected] or by phone at (630) 800-9533.

Conclusion

The Texas Cardiac Arrhythmia Institute continues to lead the way in educating healthcare providers on heart rhythm disorders, fostering collaboration, and advancing innovative treatment methods that aim to save lives and enhance patient care in the evolving landscape of cardiology.